DRGEM Corporation
DRGEM Corporation manufactures and sells diagnostic radiography systems. It offers high frequency X-ray generators; conventional and digital radiography systems; and ACQUIDR, a digital imaging system. DRGEM Corporation exports its products. The company was founded in 2003 and is headquartered in Gwangmyeong-si, South Korea.
Market Cap & Net Worth: DRGEM Corporation (263690)
DRGEM Corporation (KQ:263690) has a market capitalization of $38.40 Million (₩56.22 Billion) as of March 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #26406 globally and #1692 in its home market, demonstrating a 3.20% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying DRGEM Corporation's stock price ₩5160.00 by its total outstanding shares 10895516 (10.90 Million).
DRGEM Corporation Market Cap History: 2018 to 2026
DRGEM Corporation's market capitalization history from 2018 to 2026. Data shows change from $46.50 Million to $38.40 Million (-2.31% CAGR).
Index Memberships
DRGEM Corporation is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.61 Billion | 0.01% | #905 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.61 Billion | 0.01% | #905 of 1384 |
Weight: DRGEM Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
DRGEM Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how DRGEM Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
DRGEM Corporation's market cap is 0.00 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.00x
DRGEM Corporation's market cap is 0.00 times its annual earnings
1.94x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $46.50 Million | $56.63 Billion | $4.65 Billion | 0.00x | 0.01x |
| 2019 | $56.97 Million | $60.09 Billion | $5.47 Billion | 0.00x | 0.01x |
| 2020 | $117.60 Million | $106.60 Billion | $19.99 Billion | 0.00x | 0.01x |
| 2021 | $83.99 Million | $85.75 Billion | $12.55 Billion | 0.00x | 0.01x |
| 2022 | $76.49 Million | $110.17 Billion | $14.39 Billion | 0.00x | 0.01x |
| 2023 | $77.46 Million | $112.92 Billion | $9.19 Billion | 0.00x | 0.01x |
| 2024 | $42.27 Million | $104.01 Billion | $10.15 Billion | 0.00x | 0.00x |
Competitor Companies of 263690 by Market Capitalization
Companies near DRGEM Corporation in the global market cap rankings as of March 19, 2026.
Key companies related to DRGEM Corporation by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
DRGEM Corporation Historical Marketcap From 2018 to 2026
Between 2018 and today, DRGEM Corporation's market cap moved from $46.50 Million to $ 38.40 Million, with a yearly change of -2.31%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩38.40 Million | -3.37% |
| 2025 | ₩39.74 Million | -5.99% |
| 2024 | ₩42.27 Million | -45.44% |
| 2023 | ₩77.46 Million | +1.27% |
| 2022 | ₩76.49 Million | -8.93% |
| 2021 | ₩83.99 Million | -28.58% |
| 2020 | ₩117.60 Million | +106.42% |
| 2019 | ₩56.97 Million | +22.53% |
| 2018 | ₩46.50 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of DRGEM Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $38.40 Million USD |
| MoneyControl | $38.40 Million USD |
| MarketWatch | $38.40 Million USD |
| marketcap.company | $38.40 Million USD |
| Reuters | $38.40 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.